Dr. Gancher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3550 N Interstate Ave
Portland, OR 97227Phone+1 503-285-9321Fax+1 503-261-2160
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Neurology, 1981 - 1987
Martinez Veterans Affairs Medical CenterInternship, Internal Medicine, 1980 - 1981
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1980
Certifications & Licensure
OR State Medical License 1982 - 2025
WA State Medical License 1997 - 2025- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 551 citationsEpisodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.D.L. Browne, Stephen T. Gancher, John G. Nutt, Ewout R. Brunt, Eric A. Smith
Nature Genetics. 1994-10-01 - 192 citationsEffect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patientsJ. G. Nutt, William R. Woodward, R. M. Beckner, C. K. Stone, K. Berggren
Neurology. 1994-05-01 - 48 citationsGilles de la Tourette syndrome is not linked to D2-dopamine receptor.Joel Gelernter, Andrew J. Pakstis, David L. Pauls, Roger Kurlan, S. T. Gancher
Archives of General Psychiatry. 1990-11-01
Grant Support
- Sublingual Apomorphine In Parkinson'S Disease--Tolerability And EfficacyNational Center For Research Resources1997–1999
- Blinded Withdrawl Of Deprenyl In Datatop EtensionNational Center For Research Resources1994–1996
- Alterations In Dopaminergic Response In ParkinsonismNational Institute Of Neurological Disorders And Stroke1992–1996
- Factors Controlling Tolerance To Apomorphine Treatment In Parkinson'S DiseaseNational Center For Research Resources1994
- Comparison Of Midodrine VS Placebo In Neurogenic Orthostatic HypotensionNational Center For Research Resources1994
- Ropinirole As Adjunct To L-DOPA In The Treatment Of Parkinson'S DiseaseNational Center For Research Resources1992–1994
- Monitoring Parkinsonism In Patients With Complex Patterns Of ResponseNational Center For Research Resources1992–1994
- Study Of Sinemet CR 25/100 In Parkinsonian Patients Without Prior TherapyNational Center For Research Resources1991–1993
- Control Of Tolerance To Chronic Apomorphine Stimulation In Parkinson'S DiseaseNational Center For Research Resources1990–1993
- Deprenyl And Tocopheral Antioxidative Therapy In ParkinsonismNational Center For Research Resources1990–1992
- Apomorphine In Parkinson'S DiseaseNational Center For Research Resources1989–1990
- Deprenyl And Tocopherol Antioxidative Therapy In ParkinsonismNational Center For Research Resources1988–1989
- Apomorphine In Parkinsons DiseaseNational Center For Research Resources1988
- Is L-DOPA Excreted In BileNational Center For Research Resources1987–1988
- Pharmacokinetics Of Levodopa In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
